WHO is in talks with Pfizer to soon distribute COVID-19 vaccine globally
The WHO official said it had received a strong commitment from the Pfizer CEO, Albert Bourla, to set a reasonable price for the COVID-19 vaccine for the poor.
On December 15, senior adviser of the World Health Organization (WHO) Bruce Aylward announced that the organization is in talks with the pharmaceutical company Pfizer (USA) to soon distribute the vaccine for acute respiratory infections COVID. -19 of the firm went global.
Speaking at the press conference, Mr. Aylward said that he had received a strong commitment from the Chief Executive Officer (CEO) of Pfizer, Albert Bourla to set a reasonable price for vaccines for the poor.
He also expects to hear from several vaccine manufacturers participating in the Global COVID-19 Vaccine Outreach Mechanism (COVAX) in the coming weeks.
In addition, Advisor Aylward said WHO is looking for new sources of finance for a fund of about 28 billion USD to spend on anti-epidemic tools COVID-19.
WHO and the Global Vaccine Alliance (GAVI) are calling on donors to contribute to the ACT-Accelerator Mechanism to vaccine distributionEquitable, treatment and testing facilities in all countries, regardless of wealth and poverty.
This mechanism currently lacks $ 4.3 billion in emergency operating capital and $ 23.9 billion in 2021.
Mr. Aylward stated that new financial mechanisms, including concessional loans and disaster bonds were discussed during the ACT coordination board meeting co-chaired by Norway and South Africa.
Now, he stressed, finance is the only problem that is keeping the world from pandemic as quickly as possible.
Earlier, Canada’s International Development Minister Karina Gould announced that Canada had committed to spending $ 485 million ($ 380 million) to fund COVID-19 tests, treatment and distribution. Vaccine in low and middle income countries.
In the US, according to documents released on December 15, the US Food and Drug Administration (FDA) has no concerns about data related to the COVID-19 vaccine produced by Moderna (USA). thereby paving the way for US officials to quickly approve a second vaccine.
Moderna’s two-dose vaccine, according to the FDA, is very effective in preventing COVID-19 cases. The agency also does not raise any concerns about the safety of vaccines in people over 18 years of age.
The US is planning to distribute 40 million doses of the vaccine, enough for 20 million people, this month, including Moderna’s vaccine and the Pfizer / BioNTech vaccine.
Prior to that, the FDA issued an emergency license for the COVID-19 vaccine by the company Pfizer and BioNTech (Germany) coordinate preparation.
In another development, the European Pharmaceutical Authority (EMA) decided to meet to discuss licensing for vaccines. COVID-19 by Pfizer and BioNTech on December 21.
EMA said that after receiving the data, the agency decided to speed up the meeting time to one week, instead of waiting until December 29.
In Spain, the pharmaceutical company Reig Jofre announced it had reached an agreement with the US pharmaceutical company Johnson & Johnson to produce the COVID-19 vaccine at a factory in Barcelona city.
Under the agreement, Reig Jofre will be responsible for the composition, production and packaging for as long as the vaccine is approved by the authorities, while Johnson & Johnson’s Janssen subsidiary will be in charge of distribution.
In 2018, Reig Jofre invested 30 million euros ($ 36.4 million) to build a factory in Barcelona. The factory is expected to come into operation in Q1 / 2021 and will triple its current production capacity.
Johnson & Johnson’s COVID-19 vaccine is undergoing final testing with 60,000 people participating in more than 200 locations in the US and other countries. The test results will be announced at the end of January 2021.
On the same day, Polish Prime Minister Mateusz Morawiecki announced that the government had extracted about 3 billion zloty ($ 820.59 million) for the COVID-19 vaccine program scheduled to begin in January 2021.
Meanwhile, Polish Health Minister Adam Niedzielski recommended that people stay home during Christmas and New Year to prevent the disease from spreading. According to him, if the epidemic escalates, it will be difficult to organize effective vaccinations.